The new single-pill therapy combines cilnidipine, telmisartan and metoprolol, bringing together three established antihypertensive agents with complementary mechanisms
Cadila Pharmaceuticals’ journey has been marked by several milestones, including the development of indigenous formulations, expansion into global markets, and the creation of robust manufacturing and R&D capabilities
Vasograin Plus represents a major advancement in the treatment of migraine
A triple-action Formula for comprehensive respiratory relief
Allam was serving recently as the CEO at Public Investment Fund
The company will set-up a pharmaceuticals formulation manufacturing unit with an investment of Rs. 100 crore in Odisha
Esiloc was launched at the biggest doctor engagement webinar involving more than 12,000 doctors across the country
The Award reinforces Cadila’s digital initiatives which is backed by innovation, research & development and robust frameworks.
The ground floor of the formulation development laboratory is focused on solid orals, the first floor on injections, and the second floor houses the analytical lab
Subscribe To Our Newsletter & Stay Updated
